Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER(+) HER2(-) locally-advanced or metastatic breast cancer.
- DOI
- 10.1038/s41467-026-71233-1
- Published
- 2026 Apr 1
- Container
- Nature communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-026-71233-1,
title = {Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER(+) HER2(-) locally-advanced or metastatic breast cancer.},
author = {Liang J and Ong C and Heslop K and Guan J and Kameswaran V and Daniel B and Shi M and Liang Y and Giltnane JM and Aimi J and Chang CW and Gates MR and Eng-Wong J and Perez-Moreno P and Jhaveri KL and Turner NC and Lim E and Metcalfe C and Moore HM},
year = {2026},
journal = {Nature communications},
doi = {10.1038/s41467-026-71233-1},
url = {https://doi.org/10.1038/s41467-026-71233-1}
}RIS
TY - JOUR TI - Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER(+) HER2(-) locally-advanced or metastatic breast cancer. AU - Liang J AU - Ong C AU - Heslop K AU - Guan J AU - Kameswaran V AU - Daniel B AU - Shi M AU - Liang Y AU - Giltnane JM AU - Aimi J AU - Chang CW AU - Gates MR AU - Eng-Wong J AU - Perez-Moreno P AU - Jhaveri KL AU - Turner NC AU - Lim E AU - Metcalfe C AU - Moore HM PY - 2026 JO - Nature communications DO - 10.1038/s41467-026-71233-1 UR - https://doi.org/10.1038/s41467-026-71233-1 ER -
APA
J, L., C, O., K, H., J, G., V, K., B, D., M, S., Y, L., JM, G., J, A., CW, C., MR, G., J, E., P, P., KL, J., NC, T., E, L., C, M., & HM, M. (2026). Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER(+) HER2(-) locally-advanced or metastatic breast cancer.. Nature communications. https://doi.org/10.1038/s41467-026-71233-1
Source records
- pubmed · retrieved 2026-09-26T01:26:06.637Z